Enzyme Replacement Therapy Market
According to Intent Market Research, the Enzyme Replacement Therapy Market is expected to grow from USD 7.5 billion in 2023 at a CAGR of 9.8% to touch USD 14.4 billion by 2030. The Enzyme Replacement Therapy Market is dominated by key players such as Genzyme Corporation (Sanofi), Shire (Takeda Pharmaceuticals), Amgen Inc., Baxter International Inc., Pfizer Inc., AbbVie Inc., BioMarin Pharmaceutical Inc., Ultragenyx Pharmaceutical Inc., Mylan N.V., Kedrion Biopharma, Alexion Pharmaceuticals (AstraZeneca), Novo Nordisk, Eisai Co., Ltd., Orchard Therapeutics, Sobi (Swedish Orphan Biovitrum)